ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag national cancer institute culture ecology disease medicine developmental biology

Guts and Glory
Anna Azvolinsky | Apr 1, 2016 | 9 min read
An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.
The Ecology of Tumors
Paraic A. Kenny, Celeste M. Nelson, and Mina J. Bissell | Apr 1, 2006 | 10+ min read
FEATUREThe Ecology of Tumors   Courtesy of Nasa Ames Research CenterBy perturbing the microenvironment, wounds and infection may be key to tumor development.BY PARAIC A. KENNY, CELESTE M. NELSON, AND MINA J. BISSELLNo tumor is an island. Chemical and physical forces exerted by the diverse cellular populations that surround a tumor - its so-called microenvironment - shape development and progression. Manipulating these 'ecologi
Genes that Escape Silencing on the Second X Chromosome May Drive Disease
Amber Dance | Mar 1, 2020 | 10+ min read
When X-linked genes evade silencing on the “inactive” chromosome in XX cells, some protect women from diseases such as cancer, but others seem to promote conditions such as autoimmunity.
Dedifferentiation: More Than Reversing Fate
Ricki Lewis | Aug 29, 2004 | 5 min read
Courtesy of Cecil Fox and the National Cancer InstituteDifferentiation, the stepwise specialization of cells, and transdifferentiation, the apparent switching of one cell type into another, capture much of the stem cell spotlight. But dedifferentiation, the developmental reversal of a cell before it reinvents itself, is an important process, too. This loss of specialization is believed to factor heavily into stem-cell culture techniques and pathological conditions such as cancer. Determining its
Cancer Research Institute Recognizes Immunologists With Annual Coley Awards
Neeraja Sankaran | Aug 20, 1995 | 3 min read
Immunology Author: Neeraja Sankaran This year, the New York City-based Cancer Research Institute (CRI) honored three prominent scientists with its William B. Coley Awards for Distinguished Research, which recognize outstanding research in the field of cancer immunology. The awards were presented at a black-tie dinner on June 28. Malcolm A.S. Moore, a hematologist at Memorial Sloan-Kettering Cancer Center (MSKCC), New York, and Timothy A. Springer, a professor of pathology at the Center for Blo
Alternative Medicines
The Scientist | Jul 1, 2012 | 10+ min read
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
A fruit bat in the hands of a researcher
How an Early Warning Radar Could Prevent Future Pandemics
Amos Zeeberg, Undark | Feb 27, 2023 | 8 min read
Metagenomic sequencing can help detect unknown pathogens, but its widespread use faces challenges.
The Spin on Rotary Culture
A. J. S. Rayl | Oct 27, 2002 | 9 min read
Image: Courtesy of Leoncio A. Vergara, UTMB, Marguerite Sognier & Nasa/JSC Musculoskeletal Tissue Engineering Lab SPACE-AGE CELL CULTURE: This 3-D human rhabdomyosarcoma cell aggregate was grown in a disposable High Aspect-Ratio Vessel (HARV) in Synthecon's Rotating Cell Culture System. Biotechnology advances at a furious pace, yet for the most part, cell culture remains fixed in the past. Over the last decade, however, a new technology has emerged that models the microgravity of space--
Independent Institutes Search For New Sources Of Funding
Myrna Watanabe | Jul 6, 1997 | 7 min read
'IN TRANSITION': Association of Independent Research Institutes members are looking at new strategies, says president David Beck. Independent research institutes, which garner 10 percent of the National Institutes of Health's extramural research funding budget, rely heavily on federal support. With increased competition for grants and government funding far from assured, these institutes are reevaluating their financial strategies. Members of the Association of Independent Research Institutes
The Little Cell That Could
Megan Scudellari | Jul 1, 2012 | 7 min read
Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.

Run a Search

ADVERTISEMENT